Syntenin-1 can associate with endosome compartments, including Rab5 early endosomes, Rab7 late endosomes, and Rab11 recycling endosomes [3], and these compartments are altered in prostate cancer though changes in endosome gene expression and endosome distribution [4,5,6]. This evidence concerns the gene SDCBP and prostate cancer.